Susquehanna International Group
DMRA

Susquehanna International Group’s Damora Therapeutics, Inc. Ordinary Shares DMRA Stock Holding History

Susquehanna International Group’s Portfolio DMRA Stock Details DMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,476
Closed -$93K – 12354
2023
Q2 		$93K Buy
+1,476
New +$80.4K ﹤0.01% 11000
2023
Q1 		– Sell
-412
Closed -$11.8K – 12912
2022
Q4 		$11.8K Sell
412
-756
-65% -$31.4K ﹤0.01% 11906
2022
Q3 		$55K Buy
+1,168
New +$59.2K ﹤0.01% 12133

Other funds holding DMRA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
RCP
Remedium Capital Partners Fort Lauderdale, Florida $281M AUM

Susquehanna International Group's DMRA Position: Q1 2026 in Review

Susquehanna International Group opened a new position in Damora Therapeutics, Inc. Ordinary Shares (DMRA) in Q1 2026: 9,770 shares worth $253K. The stake represents ﹤0.01% of the portfolio and ranks #11245 among its holdings. This is a return to the name: Susquehanna International Group previously reported a position in DMRA as recently as Q2 2025.

Susquehanna International Group first reported a position in DMRA in Q4 2021 and has held it in 10 quarters since. 65 funds tracked by Wall St. Rank hold DMRA as of Q1 2026.

  • Susquehanna International Group held 9,770 shares of Damora Therapeutics, Inc. Ordinary Shares worth $253K as of Q1 2026.
  • Damora Therapeutics, Inc. Ordinary Shares was a new Susquehanna International Group position in Q1 2026.
  • Damora Therapeutics, Inc. Ordinary Shares made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #11245 holding.
  • Susquehanna International Group first reported a position in Damora Therapeutics, Inc. Ordinary Shares in Q4 2021 and has held it in 10 quarters since.
  • 65 funds tracked by Wall St. Rank held Damora Therapeutics, Inc. Ordinary Shares as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.